Notes in Rhabdomyosarcoma

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/18/2024	Paeds \| MSK \| RMS \| 1.1 \| Definition
Published	02/18/2024	Paeds \| MSK \| RMS \| 1.2 \| Epidemiology
Published	02/18/2024	Paeds \| MSK \| RMS \| 1.3 \| Aetiology
Published	02/18/2024	Paeds \| MSK \| RMS \| 1.4 \| Classification
Published	02/18/2024	Paeds \| MSK \| RMS \| 1.5 \| Pathology
Published	02/18/2024	Paeds \| MSK \| RMS \| 1.6.1 \| Biologic behaviour
Published	02/18/2024	Paeds \| MSK \| RMS \| 1.7 \| Staging and grouping
Published	02/18/2024	Paeds \| MSK \| RMS \| 1.8 \| Prognostic factors
Published	02/18/2024	Paeds \| MSK \| RMS \| 2.1 \| Workup
Published	02/18/2024	Paeds \| MSK \| RMS \| 3.2 \| Management - general
Published	02/18/2024	Paeds \| MSK \| RMS \| 3.3 \| SIOP (Eu) vs. COG (US) approaches
Published	02/18/2024	Paeds \| MSK \| RMS \| 3.4 \| Summary of IRS (Intergroup Rhabdomysarcoma Studies) studies
Published	02/18/2024	Paeds \| MSK \| RMS \| 3.1 \| Summary of treatment by IRSG-V
Published	02/18/2024	Paeds \| MSK \| RMS \| 3.6 \| Chemotherapy
Published	02/18/2024	Paeds \| MSK \| RMS \| 3.5 \| Surgery
Published	02/18/2024	Paeds \| MSK \| RMS \| 3.7 \| Radiotherapy
Published	02/18/2024	Paeds \| MSK \| RMS \| 3.8 \| Specific sites
Published	02/18/2024	Paeds \| MSK \| RMS \| 4 \| RT technique
Published	02/18/2024	Paeds \| MSK \| RMS \| 5 \| Outcomes
Published	02/18/2024	Paeds \| MSK \| RMS \| 4.2 \| Brachytherapy
Published	02/18/2024	Paeds \| MSK \| RMS \| 1.6.2 \| Clinical presentatiaon
Published	02/18/2024	Paeds \| MSK \| RMS \| 6 \| Astro 2023 summary slide
Status	Last Update	Fields